Stay updated with breaking news from Wealth Partner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Concord Wealth Partners lowered its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 82.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 60 shares of the biopharmaceutical company’s stock after selling 291 shares during the quarter. Concord Wealth Partners’ […]
Concord Wealth Partners cut its holdings in shares of ARK Innovation ETF (NYSEARCA:ARKK – Free Report) by 34.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 920 shares of the company’s stock after selling 491 shares during the quarter. Concord Wealth Partners’ holdings in […]
Concord Wealth Partners trimmed its position in shares of iShares MSCI ACWI Low Carbon Target ETF (NYSEARCA:CRBN – Free Report) by 20.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 775 shares of the company’s stock after selling 200 shares […]
Concord Wealth Partners lifted its stake in shares of GSK plc (NYSE:GSK – Free Report) by 94.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,345 shares of the pharmaceutical company’s stock after purchasing an additional 1,142 shares during the […]
Concord Wealth Partners lifted its holdings in Novo Nordisk A/S (NYSE:NVO – Free Report) by 152.1% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 426 shares of the company’s stock after purchasing an additional 257 shares during the period. Concord Wealth Partners’ holdings in […]